Claravis (Teva Pharmaceuticals USA, Inc.)


Welcome to the PulseAid listing for the Claravis drug offered from Teva Pharmaceuticals USA, Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Pharmaceuticals USA, Inc.
NON-PROPRIETARY NAME: Isotretinoin
SUBSTANCE NAME: ISOTRETINOIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Retinoid [EPC],Retinoids [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, LIQUID FILLED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2003-05-09
END MARKETING DATE: 0000-00-00


Claravis HUMAN PRESCRIPTION DRUG Details:

Item DescriptionClaravis from Teva Pharmaceuticals USA, Inc.
LABELER NAME: Teva Pharmaceuticals USA, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2003-05-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0555-1054_adc9c058-accf-49e6-b5e2-80c3daa2ad72
PRODUCT NDC: 0555-1054
APPLICATION NUMBER: ANDA076356

Other ISOTRETINOIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amneal Pharmaceuticals LLCIsotretinoin
Dr. Reddy’s Laboratories LimitedZENATANE
Mylan Pharmaceuticals Inc.Amnesteem
Physicians Total Care, Inc.Claravis
Ranbaxy Laboratories Inc.Absorica
Teva Pharmaceuticals USA, Inc.Claravis
VersaPharm IncorporatedMyorisan